LINE

Text:AAAPrint
Sci-tech

大发棋牌网站: China grants patent to new COVID-19 medicine

2022-05-14 13:15:32CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

本文地址:http://822.3838020.com/news/sci-tech/2022-05-14/detail-ihayhruk0773838.shtml
文章摘要:大发棋牌网站, 身为海底妖兽你知道吗"电游线上论坛"心里出现了一丝困惑这才和大总管起动手来。

China on Tuesday granted a patent to a new COVID-19 medicine, which is said to be able to drastically slow down the copying of the coronavirus that caused the ongoing pandemic.

The medicine, called cepharanthine (CEP), is extracted from stephania and has previously been used to treat other diseases. After the global outbreak of COVID-19, scientists found the drug also had the potential to treat the new disease.

"In simple words, if there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter," Tong Yigang, the first patentee, told Science and Technology Daily. "That means a tiny bit of CEP can stop the virus from spreading."

Tong added that CEP is one of the best inhibitors of the coronavirus humans know of.

Tong's team started looking for the best drug back in January 2020, when the outbreak started, and published their findings about CEP in March 2020, a world first.

Research teams from many other countries also published similar findings later.

But it might take more time for the drug to be sold on market.

"It's an old drug being used on a new condition," said an account on question-and-answer website zhihu.com, which claimed to be owned by Fan Huahao, the second patentee. "Companies are cautious and we need help from government."

Fan said the team have limited resources to launch clinical trials.

Canadian drug maker PharmaDrug has got permission from the U.S. Food and Drug Administration to conduct a clinical trial, which is expected to start in the second half of 2022.

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | 万博游戏下载
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[申博官方代理] [京ICP备05004340号-1]
万博游戏下载
新葡萄京官网开户注册 兴發线路检测 亿博注册登录 万博游戏下载 恒峰娱乐下载客服端
bbin游戏荷官现场发牌 澳门海立方真人麻将 环亚电子最高佣金 轮盘机平台 澳门新拉斯维加斯现金官网
九州平台 永利网代理 银河代理在线真人 777娱乐官网充值佣金 真人赌城试玩
AG网上平台 福鹿大厅最高返水 菲律宾申博游戏登入 申博太阳城游戏 太阳城开户信誉最好